Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

Next Steps for Avedro's Cross-Linking Platform

  Channels: Cornea | Posted 6/8/2016

Mark Kontos, MD, speaks with David Iannetta, Vice President of Marketing at Avedro, about newly FDA-approved corneal collagen cross-linking. Mr. Iannetta provides insight into the FDA filing process and clinical studies for Avedro’s platform. He also sheds light on a possible timeline for when devices will be available and when patients with keratoconus could start being treated.

Avedro • Corneal Collagen Crosslinking, CXL • Keratoconus

35 / 72 Series: Ophthalmology Insider

More Videos in this Series